NCT00745771

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Multiple Dose, Double-Blind, Double-Dummy, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness From Exercise

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 168 (actual)
• Sponsor: IDEA AG · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Multiple-dose, double-blind, double-dummy, parallel, randomized, placebo and active controlled study of pharmacokinetics of Diractin® as well as safety and efficacy for muscle soreness from exercise.

Conditions

• Muscle Soreness

Interventions

Type	Name	Description
DRUG	Diractin
DRUG	Diractin

Timeline

• Start date: 2007-10-01
• Primary completion: 2008-02-01
• Completion: 2008-11-01
• First posted: 2008-09-03
• Last updated: 2009-03-20

Locations

1 site across 1 country: Germany